Thymidine exerts anti-doxorubicin-induced cardiomyopathy effect through the regulation of the PPAR signaling pathways and ferroptosis pathways
Thy may exert its anti-DOX-induced cardiomyopathy effect through the regulation of the PPAR signaling and ferroptosis pathways.
Authors
- Chen Sun (ORCID: https://orcid.org/0000-0003-0657-207X)
- Peihai Li (ORCID: https://orcid.org/0000-0002-4215-8485)
- Yun Liang Zhang (ORCID: https://orcid.org/0000-0002-5060-1213)
- Bin Li (ORCID: https://orcid.org/0000-0002-7123-6286)
- Qifei Wang (ORCID: https://orcid.org/0009-0000-5276-5118)
- Juan Zhou (ORCID: https://orcid.org/0000-0002-4711-9872)
- Qing Xia (ORCID: https://orcid.org/0000-0003-0386-5686)
Institutions
- Qilu University of Technology (CN)
- Shandong Iron and Steel Group (China) (CN)
- Shandong Academy of Sciences (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3389/fphar.2025.1524167
- Primary Topic
- Congenital heart defects research
- Type
- article
- Field-Weighted Citation Impact
- 0.00